Does prasugrel achieve superior platelet inhibition when compared with clopidogrel in patients with CAD?

被引：0
|
作者：
Meinrad Gawaz
机构：
[1] Eberhard-Karls University of Tübingen,professor and Director of the Department of Medicine
来源：
Nature Clinical Practice Cardiovascular Medicine | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：648 / 649
页数：1
相关论文
共 50 条
  • [11] Inhibition of platelet aggregation with prasugrel and clopidogrel: An integrated analysis in 846 subjects
    Li, Ying G.
    Ni, Lan
    Brandt, John T.
    Small, David S.
    Payne, Christopher D.
    Ernest, C. Steven, II
    Rohatagi, Shashank
    Farid, Nagy A.
    Jakubowski, Joseph A.
    Winters, Kenneth J.
    PLATELETS, 2009, 20 (05) : 316 - 327
  • [12] Platelet inhibition with prasugrel (CS-747) versus clopidogrel in patients undergoing coronary stenting (JUMBO platelet substudy)
    Serebruany, V.
    Midei, M.
    Meilman, H.
    Malinin, A.
    Lowry, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 393 - 393
  • [13] Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention - The prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial
    Wiviott, Stephen D.
    Trenk, Dietmar
    Frelinger, Andrew L.
    O'Donoghue, Michelle
    Neumann, Franz-Josef
    Michelson, Alan D.
    Angiolillo, Dominick J.
    Hod, Hanoch
    Montalescot, Gilles
    Miller, Debra L.
    Jakubowski, Joseph A.
    Cairns, Richard
    Murphy, Sabina A.
    McCabe, Carolyn H.
    Antman, Elliott M.
    Braunwald, Eugene
    CIRCULATION, 2007, 116 (25) : 2923 - 2932
  • [14] Clopidogrel, prasugrel, ticagrelor and platelet inhibition in patients after percutaneous coronary intervention: effects on endothelial function
    Oikonomou, E.
    Siasos, G.
    Kokkou, E.
    Oikonomou, E.
    Zaromitidou, M.
    Tsalamandris, S.
    Anastasiou, M.
    Vavuranakis, M.
    Ververeli, C.
    Maniatis, K.
    Zografos, T.
    Antonopoulos, A. S.
    Mourouzis, K.
    Giannaki, A.
    Tousoulis, D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1232 - 1232
  • [15] Dual Platelet Inhibition with Clopidogrel, Prasugrel and Ticagrelor in Patients with acute Coronary Syndrome in Daily clinical Practice
    Rezaei, Safoura Sheikh
    Heinze, Georg
    Geroldinger, Angelika
    Reichardt, Berthold
    Wolzt, Michael
    INTERNIST, 2017, 58 : S26 - S26
  • [16] Is prasugrel superior to clopidogrel for patients with acute coronary syndromes undergoing PCI?
    Bhatt, Deepak L.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2008, 5 (05): : 252 - 253
  • [17] Is prasugrel superior to clopidogrel for patients with acute coronary syndromes undergoing PCI?
    Deepak L Bhatt
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 : 252 - 253
  • [18] Greater inhibition of platelet aggregation with a prasugrel 60 mg loading dose compared with a clopidogrel 600 mg loading dose in aspirin-treated patients
    Varenhorst, C.
    Braun, O.
    James, S.
    Erlinge, D.
    Winters, K. J.
    Brandt, J. T.
    Jakubowski, J. A.
    Costigan, T.
    Siegbahn, A.
    Wallentin, L. C.
    EUROPEAN HEART JOURNAL, 2007, 28 : 189 - 189
  • [19] The Onset of Inhibition of Platelet Aggregation With Prasugrel Compared With Clopidogrel Loading Doses Using Gatekeeping Analysis of Integrated Clinical Pharmacology Data
    Zhu, Baojin
    Effron, Mark B.
    Kulkarni, Pandurang M.
    Li, Ying G.
    Jakubowski, Joseph A.
    Miller, Debra L.
    Baker, Brian A.
    Luo, Junxiang
    Small, David S.
    Winters, Kenneth J.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2011, 57 (03) : 317 - 324
  • [20] Platelet reactivity with clopidogrel versus prasugrel in patients with systolic heart failure
    Dobesh, Paul
    Thomas, Deepak
    Schweitzer, Abigail
    Louie, Timothy
    Lowes, Brain
    Reha, Craig
    Oestreich, Julie
    PHARMACOTHERAPY, 2016, 36 (12): : E213 - E214
12345